Altium Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Altium Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-130,000	Closed	-$3.16M	–	105
2023 Q1	$3.16M	Sell	130,000 -60,000	-32%	-$1.31M	1.76%	21
2022 Q4	$4.07M	Buy	190,000 +65,000	+52%	+$1.39M	2.07%	16
2022 Q3	$2.24M	Sell	125,000 -111,000	-47%	-$1.46M	0.82%	47
2022 Q2	$2.27M	Hold	236,000	–	–	0.91%	43
2022 Q1	$3.97M	Sell	236,000 -93,101	-28%	-$1.38M	1.33%	31
2021 Q4	$5.5M	Buy	329,101 +1,000	+0.3%	+$16.4K	1.52%	17
2021 Q3	$5.33M	Sell	328,101 -574,532	-64%	-$6.25M	1.4%	25
2021 Q2	$5.7M	Hold	902,633	–	–	1.32%	21
2021 Q1	$5.58M	Hold	902,633	–	–	1.55%	12
2020 Q4	$6.24M	Buy	+902,633	New	+$5.78M	2.33%	4

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Altium Capital Management's ISEE Position: Q2 2023 in Review

Altium Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 130,000 shares — an estimated $3.16M sold.

Altium Capital Management first reported a position in ISEE in Q4 2020 and held it in 10 quarters. The position peaked at $6.24M in Q4 2020. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Altium Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Altium Capital Management sold 130,000 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $3.16M.
Altium Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
Altium Capital Management's IVERIC bio, Inc. Common Stock position peaked at $6.24M in Q4 2020.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Altium Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.